CBSNews.com
/
CBS Evening News
/
CBS This Morning
/
60 Minutes
/
Sunday Morning
/
Face the Nation
/
48 Hours
Markets
Investing
Tech
Leadership
Small Business
Saving
Spending
Retirement
Video
Log In
Log In
Join CBSNews.com
Sign in with
My Profile
Manage my newsletter subscriptions
Update my e-mail address
Change my password
Log Out
Get
Recent Quotes
View Full List
/
Top Indices
Dow Jones Industrials
Nasdaq Composite
S&P 500
NYSE Composite
NYSE MKT Composite
ISOTECHNIKA PHAR
(TSX:
ISA
)
0.0350
CAD
UNCHANGED
Streaming Delayed Price
/ Updated:
5:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Options
Historical Prices
Chart
Chart
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
11,200
Open
0.0350
Bid (Size)
0.0350 (0)
Ask (Size)
0.0400 (0)
Prev. Close
0.0350
Today's Range
0.0350 - 0.0350
52wk Range
0.0250 - 0.1300
Shares Outstanding
192,871,249
Dividend Yield
N/A
Top News
More News
IIROC Trade Resumption - Isotechnika Pharma Inc.
April 17, 2013
from
Newsfile Corp News Releases
IIROC Trade Halt - Isotechnika Pharma Inc.
April 17, 2013
from
Newsfile Corp News Releases
Isotechnika Provides Merger Update and Announces Financings
April 17, 2013
from
GlobeNewswire News Releases
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results
March 18, 2013
2012 Q4 net revenues grew 17.2% to RMB164.0 million (US$26.3 million))
Read More
from
PR Newswire
More News
Read More
IIROC Trade Resumption - Isotechnika Pharma Inc.
February 05, 2013
from
Newsfile Corp News Releases
Isotechnika Merger With Aurinia to Create Leading Nephrology Company
February 05, 2013
from
GlobeNewswire News Releases
IIROC Trade Halt - Isotechnika Pharma Inc.
February 05, 2013
from
Newsfile Corp News Releases
ILJIN Withdraws Damages Claims Against Isotechnika
January 15, 2013
from
GlobeNewswire News Releases
Isotechnika Announces That Lux Biosciences' Phase 3 Uveitis Study Did Not Meet Primary Endpoint
December 27, 2012
from
GlobeNewswire News Releases
Isotechnika Pharma's NICAM Compounds Demonstrate Positive Anti-Hepatitis C Virus Activity in Secondary Level Testing at NIH-Funded Labs
December 06, 2012
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
